AI has the potential to transform discovery. However, to ensure real impact, there are several practicalities that organisations must consider when implementing AI.
In this webinar, Darren Green (former Head of Cheminformatics and Data Science, GlaxoSmithKline ), John Overington (CTO, Exscientia) and Matt Segall (CEO, Optibrium) explore these key considerations for success.
Our experts debate:
- The areas of drug discovery where AI holds the greatest potential
- How to measure impact and ROI confidently
- What’s needed to drive AI adoption across discovery teams
- The main adaptations organisations should consider to increase the impact of AI
First recorded Tuesday 1st October.
